Hoth Therapeutics (HOTH) said Wednesday its board approved the purchase of up to $1 million in bitcoin.
"As bitcoin continues to grow, gaining investor attention and acceptance as a major and primary asset class, we believe that bitcoin will serve as a strong treasury reserve asset," Hoth Chief Executive Robb Knie said.
The biopharmaceutical company's shares were up 7.3% in recent trading.
Price: 0.88, Change: +0.06, Percent Change: +7.33
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。